Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-011863·Prosight Management, LP
Schedule 13G ownership disclosure
VINCERX PHARMA INC
Common Stock, $0.0001 par value per share · CUSIP: 92731L304
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Prosight Management, LP
Shares: 111,755.00 · Class: 4.99%
- Prosight Fund, LP
Shares: 9,662.00 · Class: 0.4%
- Prosight Plus Fund, LP
Shares: 30,006.00 · Class: 1.3%
- Prosight Partners, LLC
Shares: 111,755.00 · Class: 4.99%
- W. Lawrence Hawkins
Shares: 111,755.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-011863
- Form type
- SCHEDULE 13G/A
- Filer
- Prosight Management, LP
- CIK
- CIK 1617201
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership